LLY Stock Chart & Stats
C$42.66
-C$1.08(-2.47%)
―
--
Day’s Range― - ―
52-Week RangeC$30.67 - C$44.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
C$1.59T
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)42.1
Beta0.90
Next Earnings
Aug 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.31
Shares Outstanding5,100,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Eli Lilly and Company Canadian Depositary Receipt News
LLY FAQ
What was Eli Lilly and Company Canadian Depositary Receipt’s price range in the past 12 months?
Eli Lilly and Company Canadian Depositary Receipt lowest stock price was C$30.67 and its highest was C$44.80 in the past 12 months.
What is Eli Lilly and Company Canadian Depositary Receipt’s market cap?
Eli Lilly and Company Canadian Depositary Receipt’s market cap is C$1.59T.
When is Eli Lilly and Company Canadian Depositary Receipt’s upcoming earnings report date?
Eli Lilly and Company Canadian Depositary Receipt’s upcoming earnings report date is Aug 05, 2026 which is in 22 days.
How were Eli Lilly and Company Canadian Depositary Receipt’s earnings last quarter?
Eli Lilly and Company Canadian Depositary Receipt released its earnings results on Apr 30, 2026. The company reported C$0.309 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Eli Lilly and Company Canadian Depositary Receipt overvalued?
According to Wall Street analysts Eli Lilly and Company Canadian Depositary Receipt’s price is currently Undervalued.
Does Eli Lilly and Company Canadian Depositary Receipt pay dividends?
Eli Lilly and Company Canadian Depositary Receipt pays a N/A dividend of C$0.062 which represents an annual dividend yield of N/A. See more information on Eli Lilly and Company Canadian Depositary Receipt dividends here
What is Eli Lilly and Company Canadian Depositary Receipt’s EPS estimate?
Eli Lilly and Company Canadian Depositary Receipt’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eli Lilly and Company Canadian Depositary Receipt have?
Eli Lilly and Company Canadian Depositary Receipt has 5,100,000 shares outstanding.
What happened to Eli Lilly and Company Canadian Depositary Receipt’s price movement after its last earnings report?
Eli Lilly and Company Canadian Depositary Receipt reported an EPS of C$0.309 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 9.701%.
Which hedge fund is a major shareholder of Eli Lilly and Company Canadian Depositary Receipt?
Currently, no hedge funds are holding shares in TSE:LLY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Eli Lilly and Company Canadian Depositary Receipt Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
101.30%
Trailing 12-Months
Asset Growth
26.45%
Trailing 12-Months
Company Description
Eli Lilly and Company Canadian Depositary Receipt
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.
Eli Lilly and Company Canadian Depositary Receipt (LLY) Earnings & Revenues
Roche Holding Ltd CAD Hedged CIBC CDR
―
Novartis AG CAD Hedged CIBC CDR
―
Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged
―
Johnson & Johnson Shs
―
Merck & Co., Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S
―